Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04561362
Title Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Solid Tumors Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bicycle Tx Limited
Indications

pancreatic cancer

esophageal cancer

lung non-small cell carcinoma

triple-receptor negative breast cancer

transitional cell carcinoma

ovarian cancer

Advanced Solid Tumor

stomach cancer

Therapies

BT8009

BT8009 + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.